Advertisement

Topics

Search Results for "Dr David Tan Desire System"

23:27 EST 10th February 2016 | BioPortfolio

Matching Channels

Matching News

FDA approves first treatment for sexual desire disorder

The U.S. Food and Drug Administration today approved Addyi (flibanserin) to treat acquired, generalized hypoactive sexual desire disorder (HSDD) in premenopausal women. Prior to Addyi’s approval, th...

New Sexual Desire Disorder Drug

The first drug to treat acquired generalized hypoactive sexual desire disorder (HSDD) in premenopausal women has gained FDA approval, with a boxed warning and special requirements for prescribers. Fli...

Innovation Boosts Study of Fragile Biological Samples

New system sprang from a desire to better preserve ibosome crystals

Team Deciphers Sugar’s Siren Song

It’s the brain’s desire for calories-not sweetness-that dominates our desire for sugars, according to a recent Yale study

When brain metabolism dips, desire goes up in monkeys on ‘female Viagra’

As the drug touted as “the female Viagra” comes to market, researchers at the University of Wisconsin-Madison are learning more about how the drug, called flibanserin, affects the br...

MULTIMEDIA RELEASE -- Lumenis' LightSheer(R) DESIRE(TM) Laser Hair Removal System Receives the Core77 Design Award

YOKNEAM, Israel, July 30, 2015 (GLOBE NEWSWIRE) -- Lumenis Ltd. (NASDAQ:LMNS), the world's largest energy-based medical device company for aesthetic, surgical and ophthalmology applications, today an...

FDA approves Addyi, Sprout’s ‘female Viagra’

David SalazarThe Food and Drug Administration handed down its anticipated approval of Sprout Pharmaceuticals’ Addyi, a treatment for women with generalized hypoactive sexual desire disorder.&nbs...

FDA Embraces Sex Pill For Women; Restrictions Apply

Specifically, Addyi is indicated as a once-daily treatment for premenopausal women with acquired, generalized hypoactive sexual desire disorder (HSDD) as characterized by low sexual desire that causes...

Matching PubMed Articles

On Becoming a Pharmacologist: Channeling David Triggle.

This Festschrift contribution summarizes the perspectives of two of David Triggle's graduate students. Both share somewhat parallel scientific and career paths-i.e., enrolling in the Biochemical Pharm...

Sexual Desire Inventory: Two or Three Dimensions?

The Sexual Desire Inventory (SDI), developed by Spector, Carey, and Steinberg in 1996, has been widely used to assess sexual desire in men and women throughout the world. This questionnaire categorize...

Efficacy and Safety of Flibanserin in Women with Hypoactive Sexual Desire Disorder: A Systematic Review and Meta-Analysis.

Flibanserin, is a postsynaptic agonist of serotonin receptor 1A and an antagonist of serotonin receptor 2A, has been shown to increase sexual desire and reduce distress in women with hypoactive sexual...

Body Image in Dyadic and Solitary Sexual Desire: The Role of Encoding Style and Distracting Thoughts.

This study explored the link between body image and desire to engage in sexual activity (dyadic and solitary desire) in adult women living in a long-term couple relationship. Moreover, it considered t...

To be or not to be in sexual desire: the androgen dilemma.

The androgen milieu and sexual desire in women seem to be tightly linked because they both decline with age. However, we are still missing a cut-off plasma level for androgens (total testosterone, fre...

Search Whole site using Google

Loading
Quick Search
Advertisement
 
Advertisement Advertisement